MB Venture Partners
MB Venture Partners is a Memphis-based venture capital firm founded in 2001 that invests in early-stage medical device startups focused on musculoskeletal disease, managing $120 million across four funds and sourcing deals through its long-running MNVC conference.
- Company typePrivate
- Founded2001
- HeadquartersMemphis, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MB Venture Partners does
MB Venture Partners is a Memphis, Tennessee-based venture capital firm founded in 2001 by Gary Stevenson and Joseph R. "Pitt" Hyde III, specializing in early-stage life sciences investments with a focus on medical device startups addressing musculoskeletal disease. The firm has raised $120 million in committed capital across four funds and operates with a small team (1-10 employees), deploying capital primarily into Southeast US-based orthopedic and related ventures. Its current portfolio includes Cast21, Convey, SpineWave, and SweetBio, while historical exits have been acquired by major medical device strategics including Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now Stryker).
The firm's core operating asset is the Musculoskeletal New Ventures Conference (MNVC), which it has hosted for more than 21 years as a deal-sourcing and industry-relationship platform connecting musculoskeletal entrepreneurs with strategic acquirers and investors. MB Venture Partners maintains institutional partnerships with the Memphis Bioworks Foundation and the University of Memphis to anchor regional deal flow and talent access. Revenue is generated through standard venture fund economics: annual management fees on committed capital plus episodic carried interest realizations tied to portfolio exits, though specific financial terms are not publicly disclosed.
MB Venture Partners firmographics
Firmographics- Name
- MB Venture Partners
- Legal name
- MB Venture Partners
- Website
- https://mbventures.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MB Venture Partners is a Memphis-based venture capital firm founded in 2001 that invests in early-stage medical device startups focused on musculoskeletal disease, managing $120 million across four funds and sourcing deals through its long-running MNVC conference.
- Ownership category
- akta.pro rank
MB Venture Partners industry classification
Industry- Product category
- Venture Capital / Life Science Investing
- NAICS
- All Other Financial Investment Activities (52399), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where MB Venture Partners is headquartered
LocationHeadquarters
- HQ city
- Memphis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MB Venture Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Investment Returns and Management Fees: MB Venture Partners generates returns through capital appreciation of portfolio companies, realized gains from acquisitions and exits, and management fees from managing the four venture funds. The firm has documented successful exits to major medical device companies including Johnson and Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now Stryker).
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MB Venture Partners product offering
Product offeringCore offering
MB Venture Partners is a Memphis-based venture capital firm that provides capital and strategic direction to life science companies, primarily medical device start-ups at all stages of development, with particular focus on musculoskeletal disease product solutions. The firm manages four funds totaling $120 million in committed capital and has invested in more than two dozen startups, with exits realized through acquisitions by Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now part of Stryker).
Product overview
MB Venture Partners is a Memphis-based venture capital firm offering a single unified investment service focused on life science companies. The firm provides capital deployment through four managed funds ($120M in committed capital) and strategic guidance to medical device start-ups, particularly those developing product solutions for musculoskeletal disease. The firm complements its investment activities by hosting the annual Musculoskeletal New Ventures Conference (MNVC), which serves as a platform for entrepreneurs to present new ideas and for the firm to identify potential investment opportunities.
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Capital Investment Services Provides capital investment and strategic direction to early-stage and growth-stage medical device startups, with a focus on musculoskeletal disease solutions across spine, trauma, sports medicine, biologics, diagnostics, and extremities. The firm deploys limited-partner capital through four managed funds and supports portfolio companies with board participation, strategic guidance, and access to its network of medical device acquirers.
Quantifiable outcome
- All major medical device acquirers (Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical/Stryker) have acquired MBVP-funded start-ups
Companies that use MB Venture Partners
Customer profileSegments2 records
Ideal customer profiles1 record
MB Venture Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MB Venture Partners partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Memphis Bioworks FoundationcoreMB Venture Partners collaborated with the Memphis Bioworks Foundation to establish the Musculoskeletal New Ventures Conference. The initial motivation was to feature the relative strengths of Memphis in the musculoskeletal industry. The Foundation helped get the conference started, and MBVP became increasingly involved as hosts the next year.
- University of MemphiscoreThe Musculoskeletal New Ventures Conference is held annually at the FedEx Institute of Technology at the University of Memphis, providing a venue partnership for the premier musculoskeletal industry event hosted by MBVP.
Scale indicators3 records
Recent moves5 records
Expansion highlights3 records
MB Venture Partners competitors and assessment
Company assessmentEmerging players
- HealthCare Royalty Partners: Healthcare-focused investment firm providing capital to healthcare innovation, including medical device and life sciences companies. Adjacent comparability given shared focus on healthcare royalty/venture-style investing.
Direct peers
- Longitude Capital: Healthcare-focused venture capital firm investing in medical devices and biotechnology. Comparable business model and target portfolio composition to MBVP's medical device investing strategy.
- ARCH Venture Partners: Early-stage venture capital firm focused on life sciences, including medical devices and biotechnology. Comparable as a sector-specialist VC backing science-driven healthcare companies across stages.
- SV Health Investors: Dedicated healthcare and life sciences venture capital and growth equity firm. Closely mirrors MBVP's vertical specialization in life sciences investing and partnership-driven model with strategic acquirers.
- Domain Associates: Healthcare-focused venture capital firm with deep medical device investing heritage. Comparable as a sector-specialist VC that has historically backed medical device companies with strategic exit pathways.
- HBM Partners: Healthcare-focused investment firm investing across private and public life sciences companies. Comparable as a specialized healthcare investor with venture-stage and growth-stage exposure.
- Versant Ventures: Healthcare-focused venture capital firm investing across medical devices, biotech, and healthcare services. Directly comparable as a sector-specialist VC with multi-stage healthcare investing experience analogous to MBVP's medical device focus.
- Pappas Ventures: Life sciences-focused venture capital firm investing in therapeutics, medical devices, and diagnostics. Highly comparable given parallel focus on early-stage medical device and life science opportunities.
Broad incumbents
- Novo Holdings (Novo Ventures): Holding company of Novo Nordisk Foundation with major life sciences venture investing arm. Comparable as a large, sector-specialist life sciences investor with multi-stage healthcare exposure.
- OrbiMed: Largest dedicated healthcare investment firm globally, with deep medical device and life sciences exposure. Comparable as a healthcare-focused VC operating at greater scale with similar therapeutic vertical emphasis.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
MB Venture Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
MB Venture Partners leadership team
Management profileNumber of profiles
Profiles3 records
MB Venture Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MB Venture Partners M&A and investment
M&A and investmentM&A
Investments91 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MB Venture Partners
What does MB Venture Partners do?
MB Venture Partners is a Memphis-based venture capital firm that provides capital and strategic direction to life science companies, primarily medical device start-ups at all stages of development, with particular focus on musculoskeletal disease product solutions. The firm manages four funds totaling $120 million in committed capital and has invested in more than two dozen startups, with exits realized through acquisitions by Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now part of Stryker).
Is MB Venture Partners a public or private company?
MB Venture Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MB Venture Partners founded?
MB Venture Partners was founded in 2001. It employs 1 to 10 people.
Where is MB Venture Partners based?
MB Venture Partners is headquartered in Memphis, United States, in the North America region.
How does MB Venture Partners make money?
One revenue line is on record: investment Returns and Management Fees.
Who are MB Venture Partners's main competitors?
HealthCare Royalty Partners is listed as an emerging player. Direct peers are Longitude Capital, ARCH Venture Partners, SV Health Investors, Domain Associates, HBM Partners, Versant Ventures and Pappas Ventures. Broad incumbents are Novo Holdings (Novo Ventures) and OrbiMed.
Does MB Venture Partners have an API?
No public API is recorded for MB Venture Partners.
What industry is MB Venture Partners in?
MB Venture Partners's product category is Venture Capital / Life Science Investing. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52399 and its SIC code is 6282.